학술논문
Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2013 13(5):559-567
Subject
Language
ISSN
2152-2650